Reducing
Cx43 expression stimulates skin wound healing. This is mimicked in models when
Cx43 function is blocked by the
connexin mimetic
peptide Gap27.
IGF-I also stimulates wound healing with
IGFBP-5 attenuating its actions. Further, the
IGF-I to
IGFBP-5 ratio is altered in diabetic skin, where
wound closure is impaired. We investigated whether Gap27 remains effective in augmenting scrape-
wound closure in human skin
wound models simulating diabetes-induced changes, using culture conditions with raised
glucose,
insulin and
IGFBP-5. Gap27 increased scrape-
wound closure in normal
glucose and
insulin (NGI) and to a lesser extent in high
glucose and
insulin (HGI).
IGF-I enhanced scrape-
wound closure in keratinocytes whereas
IGFBP-5 inhibited this response. Gap27 overcame the inhibitory effects of
IGFBP-5 on
IGF-I activity.
Connexin-mediated communication (CMC) was reduced in HGI, despite raised
Cx43, and Gap27 significantly decreased CMC in NGI and HGI.
IGF-I and
IGFBP-5 did not affect CMC.
IGF-I increased keratinocyte proliferation in NGI, and Gap27 increased proliferation in NGI to a greater extent than in HGI. We conclude that
IGF-I and Gap27 stimulate scrape-
wound closure by independent mechanisms with Gap27 inhibiting
Cx43 function. Gap27 can enhance
wound closure in diabetic conditions, irrespective of the
IGF-I:
IGFBP-5 balance.